SPRY News

ARS Pharmaceuticals, Inc. (SPRY) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before October 5, 2026

SPRY ALERT: Securities Fraud Class Action Launched Against ARS Pharmaceuticals, Inc. - October 5, 2026 Deadline

Lost Money on ARS Pharmaceuticals, Inc. (SPRY)? Contact Levi & Korsinsky Before October 5, 2026 to Join Class Action

Pomerantz LLP Highlights Class Action Against ARS Pharmaceuticals, Inc. – SPRY

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Pentair plc (PNR), Datavault AI Inc. (DVLT), and ARS Pharmaceuticals, Inc. (SPRY) Announced by Holzer & Holzer, LLC

ROSEN, NATIONAL TRIAL COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SPRY

Securities Class Action Lawsuit Filed Against ARS Pharmaceuticals, Inc. (SPRY) - Levi & Korsinsky Represents Shareholders

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – SPRY

Securities Class Action Lawsuit Filed Against ARS Pharmaceuticals, Inc. (SPRY) - Levi & Korsinsky Represents Shareholders

SPRY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!